Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Purec, a Japan-based regenerative medicine spinout of Shimane University, secured ¥300m ($2.7m) in funding on Wednesday from photography and imaging company Fujifilm. Purec is working on a treatment for osteogenesis imperfecta, a group of genetic disorders that causes fragile bones that break even from mild trauma or without apparent impact. The investment will enable Fujifilm’s…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.